|
The result was announced after market hours yesterday, 2 February 2017.
Meanwhile, the S&P BSE Sensex was down 29.70 points, or 0.11%, to 28,198.77.
On the BSE, 3,952 shares were traded on the counter so far as against the average daily volumes of 1,053 shares in the past one quarter. The stock had hit a high of Rs 1,009 and a low of Rs 966.35 so far during the day. The stock had hit a 52-week high of Rs 1,314 on 11 March 2016 and a 52-week low of Rs 915 on 26 December 2016.
The small-cap company has equity capital of Rs 5 crore. Face value per share is Rs 2.
AstraZeneca Pharma India is engaged in the development and commercialization of medicines for core areas of healthcare, including cardiovascular/metabolic disease, cancer and respiratory, inflammatory and autoimmune disease. AstraZeneca Pharmaceuticals AB holds 75% stake in AstraZeneca Pharma India (as per the shareholding pattern as on 31 December 2016).
|